'Ambrisentan' diaporamas de présentation

Pulmonary Arterial Hypertension

Pulmonary Arterial Hypertension. Xiaosong Zhao, MD, PhD. Presbyterian Hospital of Dallas. January 3, 2006. Significance of Pulmonary arterial hypertension. Pulmonary arterial hypertension is the third cause of CHF. The median survival was 2.8 years with an estimated 5-year survival of 34%.

1.45k views • 64 slides

Learning Objectives

Learning Objectives. Utilize knowledge regarding the specific disease pathways for PAH in order to identify the sites and targets for common therapies, including prostacyclin analogs, endothelin receptor antagonists, and phosphodiesterase-5 inhibitors.

1.23k views • 59 slides

Pulmonary Hypertension: The Other High Blood Pressure

650 views • 41 slides

Pulmonary Arterial Hypertension: A Few Steps on the Long March to Effective Treatment

Pulmonary Arterial Hypertension: A Few Steps on the Long March to Effective Treatment. Edward Catherwood, MD, MS Cardiology Update, 2004. PAP. CO=. PVR. Schematic Progression of PAH. Pre-symptomatic/ Compensated. Symptomatic/ Decompensating. Declining/ Decompensated. CO.

871 views • 39 slides

Pulmonary Arterial Hypertension: A Few Steps on the Long March to Effective Treatment

Pulmonary Arterial Hypertension: A Few Steps on the Long March to Effective Treatment. Edward Catherwood, MD, MS Cardiology Update, 2004. PAP. CO=. PVR. Schematic Progression of PAH. Pre-symptomatic/ Compensated. Symptomatic/ Decompensating. Declining/ Decompensated. CO.

722 views • 39 slides

Portopulmonary Hypertension (PAH in the setting of liver disease)

Portopulmonary Hypertension (PAH in the setting of liver disease). George T. Kondos, MD Associate Professor of Medicine Department of Medicine Section of Cardiology. Classification of Pulmonary Hypertension. 1975 WHO Classification Primary pulmonary hypertension (PPH)

2.96k views • 37 slides

PH

PH . Pulmonary Hypertension. PH. Pulmonary hypertension is an abnormal elevation of the pulmonary artery pressure (PAP) and the pulmonary vascular resistance (PVR) resulting in right ventricular (RV) failure and premature death. PH.

541 views • 22 slides

Ambrisentan Impurities Manufacturer | Suppliers | Hemarsh Technologies

Ambrisentan Impurities Manufacturer and suppliers in India - Hemarsh Technologies was established in 2008 and since then our company has enjoyed a rapid growth. Our prime focus is on contract research and impurities synthesis for pharmaceutical industries.

155 views • 15 slides

Ambrisentan Industry Analysis, Market Production 2015 | Prof Research Reports

The Global and Chinese Ambrisentan Industry, 2010-2020 Market Research Report is a professional and in-depth study on the current state of the global Ambrisentan industry with a focus on the Chinese market. The report provides key statistics on the market status of the Ambrisentan manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Get Full Report at: http://www.profresearchreports.com/global-and-chinese-ambrisentan-cas-177036-94-1-industry-2015-research-report-market

248 views • 6 slides